GCB-001

· Genecombio Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for GCB-001, covering 2025-03-07 to 2025-03-07. Get the full timeline:

Most recent: Clinical Trial Update: GCB-001 in Treatment of Patients With Type II (SMA) Spinal Muscular Atrophy [NA]